EN-DALBACEN 2.0 Cohort: real-life study of dalbavancin as sequential/consolidation therapy in patients with infective endocarditis due to Gram-positive cocci

  1. Hidalgo-Tenorio, C.
  2. Sadyrbaeva-Dolgova, S.
  3. Enríquez-Gómez, A.
  4. Muñoz, P.
  5. Plata-Ciezar, A.
  6. Miró, J.M.
  7. Alarcón, A.
  8. Martínez-Marcos, F.J.
  9. Loeches, B.
  10. Escrihuela-Vidal, F.
  11. Vinuesa, D.
  12. Herrero, C.
  13. Boix-Palop, L.
  14. del Mar Arenas, M.
  15. Vázquez, E.G.
  16. de las Revillas, F.A.
  17. Pasquau, J.
Aldizkaria:
International Journal of Antimicrobial Agents

ISSN: 1872-7913,  0924-8579

Argitalpen urtea: 2023

Alea: 62

Zenbakia: 3

Mota: Artikulua

DOI: 10.1016/J.IJANTIMICAG.2023.106918 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus